IL17A and cancer: IL-17’s action on endothelial cells leads to inflammation and pro-coagulant activity, and it is also involved in innate and adaptive immune responses and has been proved to be associated with a variety of diseases, such as infectious diseases, autoimmune diseases, and cancer.